
    
      To be included in the study, subjects need to fulfil the following requirements:

        -  Diagnosis of CF, made accordingly to the CF Foundation Guideline;

        -  Ability to consciously express owns informed consent, if aged 18 or more. If minor,
           presence of at least one legally authorised parent able to consciously express informed
           consent;

        -  Have a TIVAD implanted;

        -  Have no current complications in the TIVAD (infection, thromboembolic complications or
           occlusion) Outcome Measures

      Measured outcomes will be:

        1. Incidence of TIVAD infections (Port pocket infection, Cutaneous site
           infection,Catheter-related infection;

        2. Incidence of TIVAD thrombosis;

        3. Incidence of TIVAD occlusion.

      The observational phase will last 12 months for each subject involved
    
  